Literature DB >> 17481668

Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis.

Shohei Yamaguchi1, Hirofumi Kawanaka, Daisuke Yoshida, Yoshihiko Maehara, Makoto Hashizume.   

Abstract

The enlarged spleen in liver cirrhosis is considered to play a role in the pathogenesis of portal hypertension, but the splenic hemodynamics and molecular mechanisms behind the phenomenon have not been elucidated. The present study aimed to examine the splenic hemodynamics associated with splenic microcirculation and congestion, and to determine the status of the endothelial nitric oxide synthase (eNOS) signaling pathway in the spleen of rats with liver cirrhosis. Liver cirrhosis was induced by bile duct ligation. In rats with bile duct ligation (BDL rats) and control rats, splenic blood flow was measured using a laser Doppler flowmeter, and splenic blood volume was measured using a near-infrared spectrophotometer. The expressions of eNOS and its upstream effectors, Akt, TNF-alpha and VEGF, in the spleen were also determined. Specific splenic blood flow was significantly decreased in BDL rats compared with control rats. Specific splenic blood volume was also decreased in BDL rats, while their total splenic blood volume, especially the deoxygenated volume, was significantly increased. The expressions of phosphorylated and total eNOS, and the eNOS phosphorylation ratio, were all significantly decreased in the spleen of BDL rats. The Akt phosphorylation ratio and TNF-alpha concentration were also decreased in the spleen of BDL rats although the expression of VEGF was increased. These findings suggest that the eNOS signaling pathway is suppressed in the spleen of cirrhotic rats, and may contribute to the measured decreases in specific blood flow and volume in the spleen of liver cirrhosis. Determination of the factors influencing the suppression of eNOS in the spleen may shed light on how liver cirrhosis results in hypodynamic intrasplenic circulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481668     DOI: 10.1016/j.lfs.2007.03.009

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Penicillar arterioles of red pulp in residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients: a comparative study.

Authors:  Xiaoji Zhu; Wei Han; Lei Wang; Haibo Chu; Jianhua Zhao; Yongbo Xu; Tao Wang; Wenjun Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

2.  Clinical Significance of Spleen-Remnant Liver Volume Ratio in Hepatocellular Carcinoma Surgery.

Authors:  Jiang Ou; Liu Yu; Wu Wenjian; Wu Daoquan; Xu Qiang
Journal:  Indian J Surg       Date:  2013-11-17       Impact factor: 0.656

3.  Roles of vascular endothelial growth factor and endothelial nitric oxide synthase during revascularization and regeneration after partial hepatectomy in a rat model.

Authors:  Daisuke Yoshida; Tomohiko Akahoshi; Hirofumi Kawanaka; Shohei Yamaguchi; Nao Kinjo; Akinobu Taketomi; Morimasa Tomikawa; Ken Shirabe; Yoshihiko Maehara; Makoto Hashizume
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

4.  Vascular stasis, intestinal hemorrhage, and heightened vascular permeability complicate acute portal hypertension in cd39-null mice.

Authors:  Xiaofeng Sun; Andrés Cárdenas; Yan Wu; Keichi Enjyoji; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-11       Impact factor: 4.052

5.  The technique of 3D reconstruction combining with biochemistry to build an equivalent formula of indocyanine green (ICG) clearance test to assess the liver reserve function.

Authors:  Jinli Zheng; Wei Xie; Yang Huang; Yunfeng Zhu; Li Jiang
Journal:  BMC Surg       Date:  2020-11-12       Impact factor: 2.102

Review 6.  The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jaime Arias
Journal:  J Transl Med       Date:  2007-09-24       Impact factor: 5.531

7.  Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway.

Authors:  Yunyang Chen; Weijie Wang; Huakai Wang; Yongjian Li; Minmin Shi; Hongwei Li; Jiqi Yan
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.